• Working with business

You may need to download additional plug-ins to open

• Business interaction strategy (PDF 73KB)
• Register of declared interests (PDF 37KB)

You are in

• Home
• Our organisation
• Structures
• Strategy Panels
• Bioscience for Industry Strategy Panel

Structures:

Bioscience for Industry Strategy Panel

Provides strategic input on industrial user needs and knowledge exchange activities.

Scope

The Panel will:

• Contribute to and advise on BBSRC strategies for business interaction, knowledge exchange and commercialisation (KEC), and innovation
• Advise on business needs (research, postgraduate training and skills) and relevance of BBSRC research strategy and the current research training portfolio to business
• Advise on the performance of BBSRC Institutes and Research Organisations with major investments from BBSRC in delivering knowledge exchange and commercialisation
• Advise on the performance of the BBSRC portfolio of mechanisms to support collaborative research, knowledge exchange and commercialisation including relationship with Technology Strategy Board (TSB) and impact
• Advise other BBSRC advisory bodies on issues relating to the above that are relevant to their activities
• Reporting annually to the BBSRC Executive on key issues relating to the above

Methods of working

• Two formal meetings per annum
• Ad hoc working groups (in collaboration with other BBSRC advisory bodies where appropriate) and discussion by correspondence
• Regular reports from and to BBSRC advisory bodies e.g. sector strategy groups, Bioscience Skills and Careers, Bioscience for Society as appropriate to enable the Panel to meet its responsibilities
• Regular reports from and to, as appropriate, other relevant bodies e.g. Follow-on Fund Assessment Panel, Club Steering Groups, Advanced Training Partnership Panel, Rainbow Seed Fund Board, TSB, Office of Life Sciences (OLS) as appropriate to enable the Panel to meet its responsibilities
• Regular reports on performance and evaluations of KEC mechanisms

Members

The Panel will comprise 12 members and a Chair drawn from business sectors of relevance to BBSRC and experts in KEC (including business finance). In addition there will be observers from TSB and OLS.

Dr M Lant (Chair) - Syngenta
Dr N Bradshaw - University of Bristol
Dr N Carey - Pfizer
Dr J Jones - Unilever
Dr S Martin - Independent Consultant
Professor J Murray - University of Cardiff
Mr K Norman - Velcourt
Professor R Hubbard - University of York/Vernalis
Ms C Hughes - Marks & Spencer
Professor H Sang - University of Edinburgh
Dr R Solari - GSK
Dr S Walker - Campden BRI
Mr C Warkup - Biosciences KTN
Dr S Webster - Avacta Ltd

Meeting dates and minutes

Minutes and agendas for the past 3 years can be found below. If you would like to view minutes and/or agendas older than 3 years, please contact us using the details below.

2012

19 April

2011

7 March

2010

29 April

30 September - 1 October

Contact